Burnout, Professional — The Impact of Organizational Leadership on Physician Burnout and Satisfaction
Citation(s)
Arigoni F, Bovier PA, Sappino AP Trend of burnout among Swiss doctors. Swiss Med Wkly. 2010 Aug 9;140:w13070. doi: 10.4414/smw.2010.13070. eCollection 2010.
Bianchi R, Schonfeld IS, Laurent E Burnout-depression overlap: a review. Clin Psychol Rev. 2015 Mar;36:28-41. doi: 10.1016/j.cpr.2015.01.004. Epub 2015 Jan 17. Review.
Collier R Physician burnout a major concern. CMAJ. 2017 Oct 2;189(39):E1236-E1237. doi: 10.1503/cmaj.1095496.
Dewa CS, Jacobs P, Thanh NX, Loong D An estimate of the cost of burnout on early retirement and reduction in clinical hours of practicing physicians in Canada. BMC Health Serv Res. 2014 Jun 13;14:254. doi: 10.1186/1472-6963-14-254.
Dewa CS, Loong D, Bonato S, Thanh NX, Jacobs P How does burnout affect physician productivity? A systematic literature review. BMC Health Serv Res. 2014 Jul 28;14:325. doi: 10.1186/1472-6963-14-325. Review.
Klein J, Grosse Frie K, Blum K, von dem Knesebeck O Burnout and perceived quality of care among German clinicians in surgery. Int J Qual Health Care. 2010 Dec;22(6):525-30. doi: 10.1093/intqhc/mzq056. Epub 2010 Oct 8.
Panagopoulou E, Montgomery A, Benos A Burnout in internal medicine physicians: Differences between residents and specialists. Eur J Intern Med. 2006 May;17(3):195-200.
West CP, Dyrbye LN, Shanafelt TD Physician burnout: contributors, consequences and solutions. J Intern Med. 2018 Jun;283(6):516-529. doi: 10.1111/joim.12752. Epub 2018 Mar 24. Review.
Williams ES, Manwell LB, Konrad TR, Linzer M The relationship of organizational culture, stress, satisfaction, and burnout with physician-reported error and suboptimal patient care: results from the MEMO study. Health Care Manage Rev. 2007 Jul-Sep;32(3):203-12.
The Impact of Organizational Leadership on Physician Burnout and Satisfaction at The Ottawa Hospital
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
